Literature DB >> 32601048

Covid-19: Remdesivir is recommended for authorisation by European Medicines Agency.

Jacqui Wise1.   

Abstract

Entities:  

Year:  2020        PMID： 32601048     DOI： 10.1136/bmj.m2610

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  14 in total

1.  Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis.

Authors:  Massimo Tempestilli; Giulia Valeria Stazi; Gaetano Maffongelli; Maria Cristina Marini; Tommaso Ascoli Bartoli; Giuseppe Ippolito; Emanuele Nicastri; Luisa Marchioni; Chiara Agrati
Journal:  Eur J Clin Pharmacol       Date:  2021-05-12       Impact factor: 3.064

Review 2.  FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy.

Authors:  Sylwester Drożdżal; Jakub Rosik; Kacper Lechowicz; Filip Machaj; Katarzyna Kotfis; Saeid Ghavami; Marek J Łos
Journal:  Drug Resist Updat       Date:  2020-07-15       Impact factor: 18.500

3.  A cohort study of 676 patients indicates D-dimer is a critical risk factor for the mortality of COVID-19.

Authors:  Yongsheng Huang; Xiaoyu Lyu; Dan Li; Lin Wang; Yujun Wang; Wenbin Zou; Yingxin Wei; Xiaowei Wu
Journal:  PLoS One       Date:  2020-11-09       Impact factor: 3.240

Review 4.  Current and Future Direct-Acting Antivirals Against COVID-19.

Authors:  Shiu-Wan Chan
Journal:  Front Microbiol       Date:  2020-11-12       Impact factor: 5.640

Review 5.  Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review.

Authors:  Jyoti Choudhary; Shrivardhan Dheeman; Vipin Sharma; Prashant Katiyar; Santosh Kumar Karn; Manoj Kumar Sarangi; Ankit Kumar Chauhan; Gaurav Verma; Nitin Baliyan
Journal:  Biol Proced Online       Date:  2021-02-01       Impact factor: 3.244

Review 6.  An update review of emerging small-molecule therapeutic options for COVID-19.

Authors:  Dengke Tian; Yuzhi Liu; Chengyuan Liang; Liang Xin; Xiaolin Xie; Dezhu Zhang; Minge Wan; Han Li; Xueqi Fu; Hong Liu; Wenqiang Cao
Journal:  Biomed Pharmacother       Date:  2021-02-03       Impact factor: 7.419

7.  Applying the electronic nose for pre-operative SARS-CoV-2 screening.

Authors:  Anne G W E Wintjens; Kim F H Hintzen; Sanne M E Engelen; Tim Lubbers; Paul H M Savelkoul; Geertjan Wesseling; Job A M van der Palen; Nicole D Bouvy
Journal:  Surg Endosc       Date:  2020-12-02       Impact factor: 4.584

Review 8.  Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment.

Authors:  Ke Shi; Yao Liu; Qun Zhang; Chong-Ping Ran; Jie Hou; Yi Zhang; Xian-Bo Wang
Journal:  Chin J Integr Med       Date:  2021-12-28       Impact factor: 1.978

9.  Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States.

Authors:  Essy Mozaffari; Aastha Chandak; Zhiji Zhang; Shuting Liang; Julie Gayle; Mark Thrun; Robert L Gottlieb; Daniel R Kuritzkes; Paul E Sax; David A Wohl; Roman Casciano; Paul Hodgkins; Richard Haubrich
Journal:  Open Forum Infect Dis       Date:  2021-09-28       Impact factor: 3.835

Review 10.  Tackling COVID-19 Using Remdesivir and Favipiravir as Therapeutic Options.

Authors:  Obireddy Sreekanth Reddy; Wing-Fu Lai
Journal:  Chembiochem       Date:  2020-11-11       Impact factor: 3.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.